We revisit Zymeworks Inc. following significant new trial data released this week. This triggered a 30% rally in ZYME stock on Monday, even as most of any future revenues will accrue to partners Jazz ...
Johnson & Johnson shares have underperformed for years, with multiple contributing causes including upcoming generic competition for Stelara, uncertainty around talc litigation, and questions about ...
Already known for his positional flexibility, a new defense under Mike Macdonald has demanded Rayshawn Jenkins and his Seahawks teammates to take their versatility to another level. RENTON, Wash. - ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback